Dana Gelb Safran, President and CEO, National Quality Forum, and Chief Scientific Officer, The Joint Commission, recently provided insights based on her experience as a former developer of patient experience measures at the event, "Patient-Centered Innovation: Key Steps for Clinicians, Purchasers & Payers." Read more in a new article in NEJM Catalyst: https://lnkd.in/gViRwX3x
Learn more about the evolution of patient experience measurement, the Alternative Quality Contract, and how patient experience measurement must change to meet patients' needs today from NQF President and CEO Dana Gelb Safran. Read the full article from NEJM Catalyst: https://nej.md/46I7iiM (subscription required)